USA The latest from US health care policy, including the Senate budget deal funding for a range of major health care priorities; Biden’s proposed Advanced Research Projects Agency that would reshape the government’s medical research efforts; the Senate Finance Chair’s proposal to lower prescription drug prices; the FDA’s internal investigation into…
South Africa The latest from South African pharma, including President Ramaphosa’s blunt criticism of Big Pharma, Aspen’s reception of USD 700 million in international financial aid, Adcock Ingram’s disappointing results as fewer elective surgeries and doctor visits hit their first half revenue, and the battle to bridge digital divide in COVID-19 vaccination…
Colombia The latest news from the Colombian pharma market, including a new (legal) US cannabis deal; Bayer’s updated regional strategy; a pandemic-induced OTC product boom; Faes Farma’s growth; and why prostate cancer remains a significant concern in the country. Colombia-Based Clever Leaves To Donate $25 Million Worth Of Cannabis To…
China The latest news from Chinese pharma, including a historic first approval for Fosun Kite’s CAR-T therapy Yescarta; the Big Pharma losers from the latest round of price cuts for off-patent drugs; Lonza’s new investment in Chinese API manufacturing expansion; and Dingdang Health’s recent USD 220 million financing round. Yescarta…
Brazil The latest news from Brazilian pharma, including an investigation into the country’s deal with Indian lab Bharat Biotech to purchase COVID-19 vaccines; the IP and regulatory challenges around personalised medicine in Brazil; and how domestic champion EMS surged in performance in 2020 thanks to COVID. Brazil probes Health Ministry…
Egypt As of today, the Evergreen boat that blocked global shipping when it got stuck in the Suez Canal has still not been allowed to leave Egypt. The infamous episode illustrated the complex situation that has affected global economies during the pandemic. But, for Egypt, the liberation of the canal symbolized…
Mexico The latest news from Mexican pharma, including Bayer’s big bet on oncology and Novartis’ aggressive expansion strategy as well as updates on the country’s vaccination drive, including the upcoming rollout of the J&J jab, why the country’s doctors are being denied vaccines, and the progression of trials for the Sanofi…
Asia-Pacific The latest from the pharma industry in Southeast Asia, including underwhelming results from Kalbe Pharma, Indonesia’s largest pharma company; Novavax’s vaccine manufacturing plans in the Philippines; the promising future of cannabis in Thailand; and the first Vietnamese coronavirus vaccine candidate’s Phase III trials. Indonesia’s Kalbe Farma sales underwhelm investors…
France The latest news from French pharma, including why President Emmanuel Macron’s initiative to bring medical production back to Europe has hit a wall, Sanofi’s slow progress towards finally bringing its COVID-19 vaccine candidate to market, and why investors are still betting on Valneva. Macron’s Push for German Pharma Alliance…
China The latest news from Chinese pharma, including an overhaul of the country’s patent law; a BioNTech-Fosun tie-up on COVID-19 vaccines; and big R&D subsidies for local companies available in Shanghai. How Hong Kong can cement its position as a biotech listing hub (SCMP) https://www.scmp.com/comment/opinion/article/3134767/how-hong-kong-can-cement-its-position-biotech-listing-hub To maintain its growth and…
Germany The latest news from German pharma, including a new US leadership team and more COVID-related investment at Merck KGaA; the CureVac vaccine’s role in fighting COVID-19 variants; and why the country is trailing its European neighbours in digital health. Merck KGaA’s new CEO shakes up U.S. leadership to spark…
India The latest from Indian pharma, including the year-to-year 51.5 percent growth of the pharma market in April, Lilly’s partnership with three generics makers to expand the availability of its arthritis drug baricitinib, Zydus Cadila’s upcoming approval of its COVID-19 vaccine, and the emergency use authorization for a COVID-19 antibody drug…
See our Cookie Privacy Policy Here
